SG11201703201PA - Piperidinylpyrazolopyrimidinones and their use - Google Patents
Piperidinylpyrazolopyrimidinones and their useInfo
- Publication number
- SG11201703201PA SG11201703201PA SG11201703201PA SG11201703201PA SG11201703201PA SG 11201703201P A SG11201703201P A SG 11201703201PA SG 11201703201P A SG11201703201P A SG 11201703201PA SG 11201703201P A SG11201703201P A SG 11201703201PA SG 11201703201P A SG11201703201P A SG 11201703201PA
- Authority
- SG
- Singapore
- Prior art keywords
- piperidinylpyrazolopyrimidinones
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D247/00—Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00
- C07D247/02—Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00 having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14191410 | 2014-11-03 | ||
| EP15165918 | 2015-04-30 | ||
| PCT/EP2015/075208 WO2016071216A1 (en) | 2014-11-03 | 2015-10-30 | Piperidinylpyrazolopyrimidinones and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201703201PA true SG11201703201PA (en) | 2017-05-30 |
Family
ID=54365247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201703201PA SG11201703201PA (en) | 2014-11-03 | 2015-10-30 | Piperidinylpyrazolopyrimidinones and their use |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10118930B2 (en) |
| EP (1) | EP3215505B1 (en) |
| JP (1) | JP2017533235A (en) |
| KR (1) | KR20170080647A (en) |
| CN (1) | CN107108638A (en) |
| AU (1) | AU2015342021B2 (en) |
| BR (1) | BR112017009207A2 (en) |
| CA (1) | CA2966259A1 (en) |
| HK (1) | HK1243077A1 (en) |
| IL (1) | IL251335A0 (en) |
| MX (1) | MX2017005586A (en) |
| PE (1) | PE20170920A1 (en) |
| RU (1) | RU2713937C2 (en) |
| SG (1) | SG11201703201PA (en) |
| TW (1) | TW201627308A (en) |
| UY (1) | UY36385A (en) |
| WO (1) | WO2016071216A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114874209A (en) * | 2017-03-07 | 2022-08-09 | 豪夫迈·罗氏有限公司 | Oxadiazole transient receptor potential channel inhibitors |
| WO2018224455A1 (en) | 2017-06-07 | 2018-12-13 | Basf Se | Substituted cyclopropyl derivatives |
| US11654057B2 (en) | 2020-04-09 | 2023-05-23 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
| US20240124443A1 (en) * | 2021-02-05 | 2024-04-18 | Scinnohub Pharmaceutical Co., Ltd | Plasmin inhibitor, preparation method therefor, and application thereof |
| US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO121272B1 (en) | 1996-07-24 | 2007-02-28 | The Du Pont Merck Pharmaceutical Company | Azolo triazines and pyrimidines |
| WO2004052315A2 (en) | 2002-12-11 | 2004-06-24 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| CA2527136A1 (en) * | 2003-06-03 | 2004-12-09 | Basf Aktiengesellschaft | Substituted pyrazolopyrimidines, methods for the production thereof, use of the same for controlling pathogenic fungi, and agents containing said compounds |
| WO2006023000A1 (en) | 2004-07-30 | 2006-03-02 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
| RU2390523C2 (en) * | 2005-10-21 | 2010-05-27 | Мицубиси Танабе Фарма Корпорейшн | PYRAZOLE[1,5-a]PYRIMIDINE DERIVATIVE |
| EP1873157A1 (en) * | 2006-06-21 | 2008-01-02 | Bayer Schering Pharma Aktiengesellschaft | Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| PE20080403A1 (en) | 2006-07-14 | 2008-04-25 | Amgen Inc | FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE |
| BRPI0713187A2 (en) | 2006-07-20 | 2012-10-16 | Mehmet Kahraman | method of inhibiting rho kinase, method of treating rho kinase mediated disease, compound and pharmaceutical composition |
| WO2009017954A1 (en) | 2007-08-01 | 2009-02-05 | Phenomix Corporation | Inhibitors of jak2 kinase |
| AU2008287421A1 (en) | 2007-08-10 | 2009-02-19 | Glaxosmithkline Llc | Nitrogen containing bicyclic chemical entities for treating viral infections |
| CA2706946A1 (en) | 2007-11-28 | 2009-06-04 | Schering Corporation | 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| EA020825B1 (en) | 2009-04-07 | 2015-02-27 | Эмерити Фарма Аб | Isoxazol-3(2h)-one analogs as therapeutic agents |
| WO2011140333A1 (en) | 2010-05-07 | 2011-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Identification of stabilizers of multimeric proteins |
| WO2012047156A1 (en) * | 2010-10-04 | 2012-04-12 | Astrazeneca Ab | Isoxazol-3(2h)-one analogs as plasminogen inhibitors and their use in the treatment of fibrinolysis related diseases |
| DK2649075T3 (en) | 2010-12-08 | 2018-07-30 | Us Health | SUBSTITUTED PYRAZOLOPYRIMIDINES AS GLUCOCEREBROSIDASE ACTIVATORS |
| US9440989B2 (en) * | 2012-07-18 | 2016-09-13 | Proyecto De Biomedicina Cima, S.L. | Antifibrinolytic compounds |
| CA2902686C (en) * | 2013-04-25 | 2017-01-24 | Beigene, Ltd. | Fused heterocyclic compounds as protein kinase inhibitors |
| UY35809A (en) * | 2013-11-05 | 2015-05-29 | Bayer Pharma AG | (AZA) PIRIDOPIRAZOLOPIRIMIDINONAS AND INDAZOLOPIRIMIDINONAS AND ITS USES |
-
2015
- 2015-10-30 RU RU2017119419A patent/RU2713937C2/en not_active IP Right Cessation
- 2015-10-30 AU AU2015342021A patent/AU2015342021B2/en not_active Expired - Fee Related
- 2015-10-30 SG SG11201703201PA patent/SG11201703201PA/en unknown
- 2015-10-30 KR KR1020177014874A patent/KR20170080647A/en unknown
- 2015-10-30 BR BR112017009207A patent/BR112017009207A2/en not_active Application Discontinuation
- 2015-10-30 EP EP15788013.9A patent/EP3215505B1/en active Active
- 2015-10-30 PE PE2017000789A patent/PE20170920A1/en unknown
- 2015-10-30 JP JP2017523882A patent/JP2017533235A/en active Pending
- 2015-10-30 TW TW104135708A patent/TW201627308A/en unknown
- 2015-10-30 CN CN201580072218.0A patent/CN107108638A/en active Pending
- 2015-10-30 US US15/523,954 patent/US10118930B2/en not_active Expired - Fee Related
- 2015-10-30 CA CA2966259A patent/CA2966259A1/en not_active Abandoned
- 2015-10-30 MX MX2017005586A patent/MX2017005586A/en unknown
- 2015-10-30 WO PCT/EP2015/075208 patent/WO2016071216A1/en active Application Filing
- 2015-11-03 UY UY0001036385A patent/UY36385A/en not_active Application Discontinuation
-
2017
- 2017-03-22 IL IL251335A patent/IL251335A0/en unknown
-
2018
- 2018-02-26 HK HK18102694.5A patent/HK1243077A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2713937C2 (en) | 2020-02-11 |
| AU2015342021B2 (en) | 2020-02-27 |
| WO2016071216A1 (en) | 2016-05-12 |
| UY36385A (en) | 2016-06-01 |
| EP3215505A1 (en) | 2017-09-13 |
| CN107108638A (en) | 2017-08-29 |
| KR20170080647A (en) | 2017-07-10 |
| TW201627308A (en) | 2016-08-01 |
| AU2015342021A1 (en) | 2017-05-04 |
| RU2017119419A (en) | 2018-12-05 |
| HK1243077A1 (en) | 2018-07-06 |
| CA2966259A1 (en) | 2016-05-12 |
| US20170334917A1 (en) | 2017-11-23 |
| PE20170920A1 (en) | 2017-07-12 |
| JP2017533235A (en) | 2017-11-09 |
| BR112017009207A2 (en) | 2019-10-01 |
| IL251335A0 (en) | 2017-05-29 |
| EP3215505B1 (en) | 2019-07-24 |
| US10118930B2 (en) | 2018-11-06 |
| MX2017005586A (en) | 2017-06-19 |
| RU2017119419A3 (en) | 2019-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252216A0 (en) | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | |
| HK1231471A1 (en) | 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof 6-- 6--2- | |
| GB201411197D0 (en) | Composition and use thereof | |
| PL3018183T3 (en) | Haloolefin-based composition and use thereof | |
| HUE044571T2 (en) | Modified cyclopentapeptides and uses thereof | |
| GB201401617D0 (en) | Novel combination and use | |
| IL264813B (en) | 2-oxo-imidazopyridines and their use | |
| SG11201608943VA (en) | Substituted 4-phenylpiperidines, their preparaiton and use | |
| HK1243950A1 (en) | Novel combination and use | |
| SG11201704473WA (en) | New methods and uses | |
| HK1243077A1 (en) | Piperidinylpyrazolopyrimidinones and their use | |
| GB201416727D0 (en) | Use | |
| GB201416716D0 (en) | Use | |
| GB201411196D0 (en) | Composition and use thereof | |
| GB201408091D0 (en) | Methods and uses | |
| GB2545167B (en) | Cloches and use thereof | |
| PL3229772T3 (en) | 6-aryl-9-glycosylpurines and use thereof | |
| GB201514770D0 (en) | Compounds and their use | |
| PT2923578T (en) | Snack-product and manufacture thereof | |
| GB201416073D0 (en) | Methods and uses | |
| GB201416086D0 (en) | Methods and uses | |
| GB201500278D0 (en) | Novel combination and use | |
| GB201413411D0 (en) | Novel compounds and their use | |
| GB201404728D0 (en) | Disc-over incorporating disc-heads and disc-earning | |
| GB201421960D0 (en) | Use |